Skip to main content
Erschienen in: Reactions Weekly 1/2018

01.11.2018 | Case report

Carboplatin/paclitaxel

Febrile neutropenia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Uchiyama A, et al. Efficacy and Safety of Carboplatin and Paclitaxel for Patients Preexisting Interstitial Lung Disease with Small Cell Lung Cancer. Journal of Thoracic Oncology 13 (Suppl.): S793-S794, No. 10, Oct 2018. Available from: URL: http://doi.org/10.1016/j.jtho.2018.08.1385 [abstract] - Japan Uchiyama A, et al. Efficacy and Safety of Carboplatin and Paclitaxel for Patients Preexisting Interstitial Lung Disease with Small Cell Lung Cancer. Journal of Thoracic Oncology 13 (Suppl.): S793-S794, No. 10, Oct 2018. Available from: URL: http://​doi.​org/​10.​1016/​j.​jtho.​2018.​08.​1385 [abstract] - Japan
Metadaten
Titel
Carboplatin/paclitaxel
Febrile neutropenia: case report
Publikationsdatum
01.11.2018
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-54352-2

Weitere Artikel der Ausgabe 1/2018

Reactions Weekly 1/2018 Zur Ausgabe

Case report

Lithium

Case report

Mesalazine

Case report

Cetuximab